Scientist I/II, In Vitro Pharmacology (Metabolic Disease)

Role: Scientist I/II in In Vitro Pharmacology supporting Zealand Pharma's obesity, diabetes, and metabolic disease pipeline. Objectives include designing, executing, and interpreting biochemical, biophysical, and cell-based assays to support compound screening, SAR, and mechanism-of-action studies, with a focus on GPCR pharmacology and metabolic biology. Responsibilities encompass assay development and validation, data generation and analysis, cross-functional collaboration, and advancing automation and high-throughput workflows. Qualifications: Ph.D. (0–3 years), M.S. (3–6 years), or B.S. (5+ years) in Pharmacology, Biology, Biochemistry, or related fields, with hands-on experience in assay development, GPCR biology, and metabolic disease research. Preferred skills include familiarity with biologics, biochemical/biophysical assays, cell-based functional assays, and automation platforms. High-value specifics involve work on obesity, diabetes, and metabolism projects, with a focus on preclinical in vitro studies supporting candidate advancement. Collaboration occurs across Chemistry, In Vivo Pharmacology, DMPK/Safety, and Formulation teams. The role is based in a research setting, emphasizing scientific innovation and data quality; travel requirements are not specified.